SpringWorks Therapeutics Stock Target Price and Analyst Consensus
| SWTX Stock | USD 44.00 1.11 2.59% |
The current analyst and expert consensus on SpringWorks Therapeutics is Strong Buy, with 5 strong buy opinions. The current projected SpringWorks Therapeutics target price consensus is 50.17 with 9 analyst opinions. The most common way SpringWorks Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview SpringWorks Therapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on SpringWorks Therapeutics. We strongly encourage you to use your own analysis of SpringWorks Therapeutics to validate this buy or sell advice. SpringWorks Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected SpringWorks Therapeutics target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on SpringWorks Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy SpringWorks Stock please use our How to Invest in SpringWorks Therapeutics guide.
Lowest Forecast 45.65 | Highest Forecast 55.69 | Target Price 50.17 |
SpringWorks |
It's important to approach SpringWorks Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize SpringWorks Therapeutics price targets
SpringWorks Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using SpringWorks Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at SpringWorks Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if SpringWorks Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional SpringWorks Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of SpringWorks Therapeutics is a key component of SpringWorks Therapeutics valuation and have some predictive power on the future returns of a SpringWorks Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of SpringWorks Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Business Services Invested over 100 shares | |
 | Hedge Favorites Invested over 60 shares | |
 | Macroaxis Index Invested few shares | |
 | Baby Boomer Prospects Invested over 40 shares | |
Check out Macroaxis Advice on SpringWorks Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy SpringWorks Stock please use our How to Invest in SpringWorks Therapeutics guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for SpringWorks Stock analysis
When running SpringWorks Therapeutics' price analysis, check to measure SpringWorks Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpringWorks Therapeutics is operating at the current time. Most of SpringWorks Therapeutics' value examination focuses on studying past and present price action to predict the probability of SpringWorks Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpringWorks Therapeutics' price. Additionally, you may evaluate how the addition of SpringWorks Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
The data published in SpringWorks Therapeutics' official financial statements usually reflect SpringWorks Therapeutics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of SpringWorks Therapeutics. For example, before you start analyzing numbers published by SpringWorks accountants, it's critical to develop an understanding of what SpringWorks Therapeutics' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of SpringWorks Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, SpringWorks Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in SpringWorks Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of SpringWorks Therapeutics. Please utilize our Beneish M Score to check the likelihood of SpringWorks Therapeutics' management manipulating its earnings.